L-lysine/L-arginine-containing Amino Acid
Small molecule
L-lysine/L-arginine-containing Amino Acid is one of 7 small molecule programs targeting Intracranial Meningioma. It is currently in development.
1
Indications
1
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Intracranial Meningioma
#DrugCompanyPhaseTrials
1Erivedge
RochePhase 2
Truqap
AstraZenecaPhase 2
Verzenio
Eli LillyPhase 2
Afinitor
NovartisPhase 2
Avastin
BBio-Thera Solutions
Phase 2
FAK Inhibitor GSK2256098
AAlliance for Clinical Trials in Oncology
Phase 2
L-lysine/L-arginine-containing Amino Acid
JJoshua Palmer
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Company
- JJoshua Palmer